Gilead Sciences, Inc. (GILD) vs Pfizer Inc. (PFE)
GILD leads on 10 of 15 compared metrics.
A side-by-side comparison of Gilead Sciences, Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — GILD vs PFE
growth of $100 · last 30yGILD +13408.8%PFE +128.5%GILD compounded faster
Log scale — wide-divergence pair
GILD PFE
GILD vs PFE: by the numbers
- •GILD is the larger company ($155.93B vs $149.38B market cap).
- •GILD trades at the lower earnings multiple (17.11 vs 20.01 P/E).
- •GILD converts more revenue to profit (30.99% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 3.07% CAGR).
- •PFE pays the higher dividend yield (6.56% vs 1.91%).
Which is better, GILD or PFE?
Metric tally: GILD 10 · PFE 5It depends on what you're optimizing for:
ValueGILD(lower P/E)
GrowthPFE(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityGILD(higher ROIC)
Valuation
| Metric | GILD | PFE |
|---|---|---|
| P/E ratio | 17.11● | 20.01 |
| Forward P/E | 13.00 | 9.25● |
| P/S ratio | 5.30 | 2.37● |
| P/B ratio | 6.70 | 1.67● |
| PEG ratio | 0.01 | — |
| EV / EBITDA | 12.91 | 12.72 |
| FCF yield | 6.49%● | 6.31% |
Profitability
| Metric | GILD | PFE |
|---|---|---|
| Gross margin | 79.35%● | 69.35% |
| Operating margin | 38.26%● | 23.45% |
| Net margin | 30.99%● | 11.83% |
| ROE | 39.19%● | 8.31% |
| ROIC | 21.53%● | 8.84% |
Dividends
| Metric | GILD | PFE |
|---|---|---|
| Dividend yield | 1.91% | 6.56%● |
| Payout ratio | 35.09% | 126.47% |
Growth (annualized)
| Metric | GILD | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 3.07% | 8.22%● |
| EPS CAGR (5Y) | 133.83%● | -3.78% |
| FCF CAGR (5Y) | 3.30%● | -3.79% |
| Total return CAGR (5Y) | 17.06%● | -3.33% |
Frequently asked
- Which is better, GILD or PFE?
- It depends on your goal. value: GILD (lower P/E); growth: PFE (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: GILD (higher ROIC). Across all compared metrics, GILD leads 10 to 5.
- Is GILD or PFE cheaper?
- On trailing earnings, GILD is cheaper: GILD trades at a 17.11 P/E and PFE at 20.01.
- Which has grown faster, GILD or PFE?
- Over the past five years, PFE grew revenue faster — GILD at a 3.07% CAGR versus PFE at 8.22%.
- Does GILD or PFE pay a bigger dividend?
- GILD yields 1.91% and PFE yields 6.56% based on trailing dividends and the latest price.
- Is GILD or PFE more profitable?
- GILD runs the higher net margin — GILD at 30.99% versus PFE at 11.83%.
- Which has been the better investment, GILD or PFE?
- Over the past 10-year, GILD delivered the higher annualized total return — GILD at 7.79% versus PFE at 2.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gilead Sciences P/E ratioPfizer P/E ratioGilead Sciences dividend yieldPfizer dividend yieldGilead Sciences ROEPfizer ROEGilead Sciences operating marginPfizer operating marginGilead Sciences revenue growthPfizer revenue growthGilead Sciences free cash flowPfizer free cash flow
Gilead Sciences & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.